Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients

American Journal of Physical Medicine & Rehabilitation
M B GlennM Rosenthal

Abstract

Lithium carbonate (LiCO3) was used to treat 10 brain-injured patients with severe, unremitting, aggressive, combative, or self destructive behavior or severe affective instability. Five patients had a dramatic response that resulted in significant improvement in their participation in a rehabilitative program. One other patient had a moderate response. A seventh patient improved dramatically, but regressed after 7 wk. Three other patients had neurotoxic side effects that precluded continued use of the medication. Two of them were simultaneously taking neuroleptic agents. These case reports provide further evidence that LiCO3 can be a useful medication in the treatment of aggressive behavior and affective instability after brain injury, but that it has significant potential for neurotoxicity in this population, particularly when used in conjunction with neuroleptic agents.

Citations

Sep 17, 2002·Current Psychiatry Reports·Edward Kim
Dec 21, 2000·Current Psychiatry Reports·L A Labbate, D L Warden
Nov 30, 2000·Current Treatment Options in Neurology·D B ArciniegasJ M Silver
Dec 6, 2001·Current Treatment Options in Neurology·Robin A. Hurley, Katherine H. Taber
Jan 1, 2003·Neuropsychological Rehabilitation·Peter Eames Eames, Rodger Ll Wood
Oct 6, 2006·Journal of Neurotrauma·UNKNOWN Neurobehavioral Guidelines Working GroupGeorge Zitnay
Dec 22, 2010·Neurologic Clinics·Scott D LaneF Gerard Moeller
Oct 13, 2009·Clinics in Sports Medicine·Todd LefkowitzGerard Varlotta
Jan 30, 2015·Journal of Neurotrauma·Dennis J ZgaljardicTimothy R Elliott
Jul 23, 2015·Psychosomatics·Caroline CruzJonathan T Stewart
Jun 16, 2009·Cell Transplantation·Wise Young
Oct 24, 2017·Expert Review of Neurotherapeutics·Jong S Kim
Nov 3, 2017·The Journal of Head Trauma Rehabilitation·Inder D Kalra, Thomas K Watanabe
Sep 30, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Boris P Sokolov, Jean L Cadet
Oct 6, 2005·American Journal of Physical Medicine & Rehabilitation·Lisa A Lombard, Ross D Zafonte
Mar 1, 1996·The Annals of Pharmacotherapy·D J Pabis, S W Stanislav
Oct 16, 2007·CNS Spectrums·Timothy J OsterDavid B Arciniegas
Oct 21, 2006·The Cochrane Database of Systematic Reviews·S FlemingerD L Oliver
Nov 24, 2020·The Mental Health Clinician·Sophie Robert
Jun 1, 1997·The Psychiatric Clinics of North America·M Fava

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Journal of Clinical Psychopharmacology
S W StanislavA Childs
The British Journal of Psychiatry : the Journal of Mental Science
M CraftP M North
Journal of the American Academy of Child and Adolescent Psychiatry
J E CuevaM Campbell
© 2022 Meta ULC. All rights reserved